Top

Journal of Neurology

Published in:

01-06-2018 | Letter to the Editors

Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis

Authors: Hiroki Yamaguchi, Kenji Sakai, Yoshinori Goto, Masahito Yamada

Published in: Journal of Neurology | Issue 6/2018

Excerpt

Dear Sirs, …

Villamil A, Mullen E, Casciato P et al (2015) Interferon beta 1a-induced severe autoimmune hepatitis in patients with multiple sclerosis: report of two cases and review of the literature. Ann Hepatol 14:273–280PubMed

Duchini A (2002) Autoimmune hepatitis and interferon beta-1a for multiple sclerosis. Am J Gastroenterol 97:767–768CrossRefPubMed

Mishra A, Guindi M, Kandel G et al (2015) Autoimmune hepatitis-like reaction developing in a patient treated with interferon-β1a. Histopathology 66:605–607CrossRefPubMed

Byrnes V, Afdhal N, Challies T et al (2006) Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis. Ann Hepatol 5:56–59PubMed

Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral

Wingerchuk DM, Banwel B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189CrossRefPubMedPubMedCentral

Manns MP, Czaja AJ, Gorham JD et al (2013) Diagnosis and management of autoimmune hepatitis. Hepatology 51:2193–2213CrossRef

Speciale L, Sarresella M, Caputo D et al (2000) Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b. J Neurovirol 6:S57-S61

Cação G, Santos E, Martins SA (2017) Concurrent autoimmune hepatitis in multiple sclerosis. Mult Scler 1352458517692885 (Epub ahead of print)

10.

de Seze J, Canva-Delcambre V, Fajardy I et al (2005) Autoimmune hepatitis and multiple sclerosis: a coincidental association? Mult Scler 11:691–693CrossRefPubMed

11.

Ferrò MT, Franciotta D, Riccardi T et al (2008) A case of multiple sclerosis with atypical onset associated with autoimmune hepatitis and silent coeliac disease. Neurol Sci 29:29–31CrossRefPubMed

12.

Maàmouri N, Ketari S, Ben Hariz F et al (2009) Bolus de méthylprednisolone révélant une hépatite auto-immune chez une patiente atteinte de sclérose en plaques. J Afr Hépatol Gastroentérol 3:195–197CrossRef

13.

Reuß R, Retzlaff K, Vogel S et al (2007) Autoimmune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS. Cent Eur J Med 2:356–359

14.

Takahashi A, Kanno Y, Takahashi Y et al (2008) Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. World J Gastroenterol 14:5474–5547CrossRefPubMedPubMedCentral

Title: Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis
Authors: Hiroki Yamaguchi
Kenji Sakai
Yoshinori Goto
Masahito Yamada
Publication date: 01-06-2018
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 6/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-8912-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Autoimmune hepatitis induced by a single injection of interferon-β 1a in a patient with multiple sclerosis

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2018

Wake-up stroke and sleep-disordered breathing: a meta-analysis of current studies

Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study

Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer’s disease, and Parkinson’s disease

Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia

Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson’s disease

Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance